Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: Three-year data from 2 double-blind, randomized, placebo-controlled trials

Archives of Internal Medicine

Volumn 160, Issue 22, 2000, Pages 3444-3450

  Johnston Jr , C Conrad ^a,k   Bjarnason, Nina H ^b   Cohen, Fredric J ^c,j   Shah, Aarti ^c   Lindsay, Robert ^d   Mitlak, Bruce H ^c   Huster, William ^c   Draper, Michael W ^c   Harper, Kristine D ^c,e   Heath III, Hunter ^c,f   Gennari, Carlo ^g   Christiansen, Claus ^b   Arnaud, Claude D ^h   Delmas, Pierre D ⁱ  

^a INDIANA UNIVERSITY   (United States)

^b CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^c ELI LILLY AND COMPANY   (United States)

^d HELEN HAYES HOSPITAL   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF SIENA   (Italy)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ EDOUARD HERRIOT HOSPITAL   (France)

^j R W JOHNSON PHARMACEUTICAL RES I   (United States)

^k INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RALOXIFENE;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INDUCED DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HOT FLUSH; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034639224     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.22.3444     Document Type: Article

References (24)

1. Selective estrogen receptor modulators: An alternative to hormone replacement therapy
2. Effects of raloxifene on the endometrium in healthy postmenopausal women
3. In search of optimal long-term female hormone replacement: The potential of selective estrogen receptor modulators
4. Selective estrogen receptor modulators: A look ahead
5. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
6. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
7. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
8. A new, highly responsive region of interest in the distal forearm to monitor the effect of osteoporosis treatment
9. An analysis of variance test for normality (complete samples)
10. The jackknife estimate of variance
11. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay
12. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
13. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age
14. The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding study
15. Alendronate prevents postmenopausal bone loss in women without osteoporosis: A double-blind, randomized, controlled trial
16. Alendronate increases the mean degree of mineralization of bone and the uniformity of mineralization of bone in osteoporotic women
17. Bone mineral density reflects bone mass but also the degree of mineralization of bone: Therapeutic implications
18. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
19. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
20. Hormone and nonhormone therapy for the maintenance of postmenopausal health: The need for randomized controlled trials of estrogen and raloxifene
21. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
22. Effects of raloxifene in postmenopausal women
23. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women: Italian Tamoxifen Prevention Study
24. The effect of raloxifene on risk of breast cancer in postmenopausal women